CEACAM5 and neoplasm: In vivo delayed type hypersensitivity (DTH) testing demonstrated that AEXs alone are sufficient to activate systemic anti-AEX immunity, suggesting that AEXs are immunogenic on their own and may stimulate CD8+ CTLs towards tumor antigens like carcinoembryonic antigen (CEA).